Pages
Tissue Viability
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/tissue-viability
Diabetes Education for Professionals
The information here is for professionals in Derbyshire working with patients with type 2 diabetes.
Move to Defender AntiVirus
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/move-defender-antivirus
Continence services
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/adult-services
Files
DCHS brand toolkit
DCHS Branding Guidelines and Toolkit 2021 - revised version with updated pantone ref for pink
Supporting children and young people to manage social communication difficulties V2.pdf
Toolkit about supporting older children with social communication needs. Version 2 May 2022
Abuse, Discrimination and Aggression Towards Staff Policy
Abuse, Discrimination and Aggression Towards Staff
Hammer - Claw-Mallet Toe (L13)
Hammer – Claw-Mallet Toe. Podiatric Surgery patient information leaflet.
DCHS Checking your reports letters and leaflets are easy to read
DCHS Checking your reports letters and leaflets are easy to read
L314 - Why has my GP or nurse referred me to Diabetes Education
Why has my GP or nurse referred me to Diabetes Education
Guidance for E-referrals via S1 to the Tissue Viability Service (G327)
Guidance for E-referrals via S1 to the Tissue Viability Service
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2.pdf
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2
Disclosure Ref 202481 - Nurse Referrals to Nursing Council.pdf
FOI Disclosure Ref 202481 - Nurse Referrals to Nursing Council
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010